By date

• Improvement in hearts of mdx mice lasts after Morpholino treatment ceases

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • mdx
  • mouse
  • ppmo
  • conjugate
  • cpp
  • dmd

• BIG doses of Morpholino in mice

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • mdx
  • mouse
  • dmd

• Clinical trial

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • human
  • clinical
  • trial
  • dmd

• Bare morpholino dosing regimens compared in mdx mice

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • dmd
  • mdx
  • mice

• Muscular dystrophy dog model and Morpholinos

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • dog
  • dmd
  • nih
  • splicing

• Clinical trial using Morpholinos for DMD

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • pmo
  • avi
  • splicing
  • dystrophin
  • dmd
  • duchenne

• Pharmaceutical regulations and exon-skipping oligos

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • dmd
  • duchenne
  • therapeutic
  • pharmaceutical
  • exon

• 2'-O-methyl phosphorothioates versus Morpholinos for DMD

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • dmd
  • phosphorothioate

  1 reply

  last reply:
  16 January 2009 by Jon Moulton

• Skipping exon 23 in mdx mice ameliorates cellular pathologies

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • dmd
  • mdx
  • mouse

• Therepeutic splice modification

  Posted by:

  Jon Moulton

  Tags:

  • morpholino
  • dmd
  • therapeutics